Matti Kankainen

18PUBLICATIONS
134CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematologyOrganic chemistry not elsewhere classifiedTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 14, 2026
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

|Oct 30, 2025
Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.

Aleksandr Ianevski, Kristen Nader, Julia Nguyen

|Apr 30, 2025
Clonal hematopoiesis is associated with distinct rheumatoid arthritis phenotypes.

Emil Hiitola, Juuso Korhonen, Heidi Kokkonen

|Jun 28, 2024
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses.

Jana von Jan, Sanna Timonen, Till Braun

|Jun 07, 2024
Somatic mutations associate with clonal expansion of CD8+ T cells.

Sofie Lundgren, Mikko Myllymäki, Timo Järvinen

|Aug 18, 2022
A novel partial de novo duplication of JARID2 gene causing a neurodevelopmental phenotype.

Liisa Viitasalo, Kaisa Kettunen, Matti Kankainen

Pageof 3

Frequent Collaborators

12 joint publications

Satu Mustjoki

4 joint publications

Sofie Lundgren

4 joint publications

Jani Huuhtanen

3 joint publications

Daehong Kim